Healthline lands Drugs.com ad sales deal

Share this article:
Healthline lands Drugs.com ad sales deal
Healthline lands Drugs.com ad sales deal
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.

The agreement boosts Healthline's reach to nearly 55 million monthly uniques, said the San Francisco firm, or about half the monthly health information audience, per comScore stats.

“We wanted a partner that could help marketers take advantage of our critical position in the treatment consideration process,” said Drugs.com CEO Philip Thornton. “Healthline not only gives us a roster of strategic sellers with deep DTC experience but original, engaging content and visual learning solutions that can help marketers reach consumers and healthcare providers at a critical point of decision.”

Healthline, whose backers include Kaiser Permanente, Reed Elsevier, GE/NBC Peacock Fund and Aetna, offers search, advertising and content services through partnerships with 50-plus destination sites including web publishers, portals, search engines, employers and health plans.
Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.